Recruiting

Antenatal Corticosteroids

Sponsor:

University of British Columbia

Code:

NCT04792112

Conditions

Decision Making, Shared

Pregnancy

Preterm Birth

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Decision support tool

Study Details

Brief summary:

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Conditions

Decision Making, Shared

Pregnancy

Preterm Birth

Study ID

NCT04792112

Start date

May 20, 2022

Status verified date

May, 2022

Completion date

Feb 1, 2024

Anticipated

Primary completion date

Feb 1, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 year or older.
  • Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
  • Speaks English.
  • Agrees to participate in the questionnaire during their first week post-partum.
  • Delivered at one of the six participating obstetrical hospitals.

Exclusion Criteria:

  • None.

Study Design

Enrollment

460 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Guideline + decision support tool

A decision support tool summarizing harms and benefits of late preterm antenatal corticosteroids will be integrated into the clinical practice guideline available to clinicians in the hospitals in the experimental arm.

no intervention: Guideline only

Clinicians in the hospitals in the 'no-intervention' arm will have access to the standard guideline only (without the integrated decision support tool).

Interventions

Decision support tool

Decision support tool for late preterm antenatal corticosteroids

Primary outcome measure

  • The change in frequency of clinical counselling about late preterm antenatal corticosteroids. [ Time Frame: up to 8 months following implementation of the intervention. ]

Central Contacts and Locations

Central contacts

Jessica Liauw, MD

604-875-2424jessica.liauw@phsa.ca

Locations

Surrey Memorial Hospital

Recruiting

Surrey, British Columbia, Canada, V3V 1Z2

Principal Investigator:

Jason Burrows, MD

BC Women's Hospital

Recruiting

Vancouver, British Columbia, Canada, V6H 3N1

Contacts

Jessica Liauw, MD

604-875-2424jessica.liauw@phsa.ca

More Information

Sponsor

University of British Columbia

Last update posted

Jun 2, 2022

Last verified

May, 2022

Keywords

  • Antenatal corticosteroid

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of British Columbia on 2022-06-02.